Abstract
The term PRIS—propofol infusion syndrome—was originally coined by Bray in 1998 to describe the adverse effects associated with the use of propofol in the paediatric population. PRIS was defined as acute refractory bradycardia leading to asystole in the presence of one or more of the following: metabolic acidosis (base excess of −10 mmol litre−1), rhabdomyolysis or myoglobinuria, lipaemic plasma, or enlarged liver or fatty liver.1
Keywords